oral semaglutide approval FDA-Approved Semaglutide: The First GLP-1 Pill Oral Semaglutide Shows Promise in

A limited time pop-up pushes the 50% off first-month deal

The trabecular density of GLP-1R and GIPR double KO mice was higher than that of the wild-type control group, but the cortical thickness, cortical area, and external diameter of bone decreased (Mieczkowska et al., 2015)

Over time, high blood sugar levels can damage the nerves and blood vessels, leading to severe complications

Beavers KM, et al

Over 68 weeks, the participants saw an average weight reduction of 15.8% with semaglutide, compared to 6.4% with liraglutide

More than half (54%) of those who take GLP-1s for weight loss spend less than a year on the medication, while just 18% stay on them for more than two years, according to a Sermo physician survey